Pact Pharma IPO

pactpharma.com

PACT Pharma clinical stage biotechnology company developing personalized adoptive T cell therapies for the eradication of solid tumors.

Founded2017
Total Funding to Date$266.25MM
Register for Details

For more details on financing and valuation for Pact Pharma, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Pact Pharma Ticker Symbol

Pact Pharma does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Pact Pharma Stock Price

The stock price for Pact Pharma will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Pact Pharma Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
6/15/2020 Series C-1 $514.44MM $XXX.XX $XXX.XX
1/10/2020 Series C $318.69MM $XXX.XX $XXX.XX
5/25/2018 Series B $175.59MM $XXX.XX $XXX.XX
12/20/2016 Series A $46MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like Pact Pharma in the Healthcare sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM